CT-1812 CAS:1802632-22-9
CT-1812
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-2100 | 50mg | 925.00 | + Add to cart |
|
| R-C-2100 | 100mg | 1250.00 | + Add to cart |
|
| R-C-2100 | 200mg | 1750.00 | + Add to cart |
|
|
|
||||
Product description
CT-1812 is a first-in-class,orally available sigma-2/PGRMC1 antagonist(alpha beta oligomer receptor antagonist),is being developed by Cognition.sCT-1812 is a novel therapeutic candidate for Alzheimer is disease.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---CT-1812
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


